Benign breast disease.
作者信息
Mauvais-Jarvis P, Kuttenn F
机构信息
Necker School of Medicine, Descartes University, Paris, France.
出版信息
Curr Ther Endocrinol Metab. 1994;5:364-70.
PMID:7704754
Abstract
摘要
相似文献
1
Benign breast disease.良性乳腺疾病
Curr Ther Endocrinol Metab. 1994;5:364-70.
2
Management of breast pain.乳腺疼痛的管理
Int J Clin Pract. 2000 May;54(4):228-32.
3
[Mastodynia and fibrocystic disease of the breast. Perspectives and methods of medical treatment].[乳腺疼痛和乳腺纤维囊性疾病。医学治疗的观点和方法]
J Gynecol Obstet Biol Reprod (Paris). 1986;15(6):805-11.
4
[Update in the therapy of fibrocystic mastopathy].[乳腺纤维囊性变的治疗进展]
Minerva Ginecol. 1987 Dec;39(12):833-8.
5
[Treatment of benign breast pathology with bromocriptine].[用溴隐亭治疗良性乳腺病变]
Riv Ital Ginecol. 1977 Sep-Oct;58(5):371-8.
6
[Endocrinological aspects of fibrocystic mastopathy].[纤维囊性乳腺病的内分泌学方面]
Recenti Prog Med. 1982 Jan;72(1):31-64.
7
[Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].[抗催乳素疗法治疗乳腺良性病变。溴隐亭与麦角新碱的比较]
Minerva Med. 1979 Nov 17;70(51):3493-8.
8
Behaviour of estrogen receptor, histological correlation, and clinical outcome in patients with benign breast disorders.良性乳腺疾病患者雌激素受体的行为、组织学相关性及临床结局
Eur J Surg. 2002;168(11):631-4. doi: 10.1080/11024150201680011.
9
Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).用2-溴-α-麦角隐亭（CB 154）治疗乳腺良性纤维囊性疾病。
Int J Clin Pharmacol Ther Toxicol. 1982 Oct;20(10):479-81.
10
[Bromocriptine in fibro-cystic mastopathy].[溴隐亭治疗纤维囊性乳腺病]
Riv Ital Ginecol. 1980;59(4-5):357-64.
Zotero 插件